- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 291.19M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $100.59M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $135.4M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $818K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $818K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $107.61M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $50.14M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $89.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $202.97M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $198.47M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $347.49M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $148.23M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $93.76M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $396.27M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $343.78M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 187.28M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $38K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$14.36M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $143.17M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$30M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.68 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.68 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $16.95M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$127.79M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$98.07M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $6.99M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $26.14M |
| Revenue | Q1 2025 · Mar 31, 2024 | $33.12M |